Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation Therapy
Open Access
- 17 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 41 (4), 537-542
- https://doi.org/10.1093/jjco/hyq242
Abstract
The aim of this study was to evaluate the effect of the primary tumor volume on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Between August 2003 and April 2005, 112 patients with Stage I–IVB nasopharyngeal carcinoma treated by intensity-modulated radiation therapy were included. Measurement of the primary tumor volume was based on contrast-enhanced computed tomography scans before treatment. A receiver operating characteristics curve was used to determine the best cut-off point of the primary tumor volume. The mean primary tumor volume for 112 patients with nasopharyngeal carcinoma was 33.9 ± 28.7 ml. Within the framework of UICC T-staging, all patients were divided into four groups according to the primary tumor volume. We call it the volume stage (V1 50.55 ml). The 5-year overall survival rates for V1, V2, V3 and V4 were 88.5, 83.3, 82.4 and 54.5% (P = 0.014), respectively. The cumulative survival curves for V1, V2 and V3 were very close, but clearly separated from V4. In addition, Cox proportional hazards regression model analysis showed that a primary tumor volume >50 ml was an independent risk factor for radiotherapy (risk ratio = 3.485, P = 0.025). This study demonstrated that the primary tumor volume had significantly impacted on the prognosis of patients with nasopharyngeal carcinoma. We proposed that the primary tumor volume should be considered as an additional stage indicator in the new revision of the clinical stage of nasopharyngeal carcinoma.Keywords
This publication has 19 references indexed in Scilit:
- Dosimetric Comparison Between 2-Dimensional Radiation Therapy and Intensity Modulated Radiation Therapy in Treatment of Advanced T-Stage Nasopharyngeal Carcinoma: To Treat Less or More in the Planning Organ-At-Risk Volume of the Brainstem and Spinal CordMedical Dosimetry, 2007
- Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Focus on nasopharyngeal carcinomaCancer Cell, 2004
- Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volumeInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineationInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neckHead & Neck, 2003
- Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalationInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Prognostic significance of tumor oxygenation in humansCancer Letters, 2003
- pH, Hypoxia and MetastasisPublished by Wiley ,2001
- Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasisInternational Journal of Radiation Oncology*Biology*Physics, 1998